- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Spinal muscular atrophy (SMA)
- Meeting Date: July 2020
- Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 1918KB)
- Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 676KB)
Nusinersen – July 2020
Nusinersen: Solution for injection 12 mg in 5 mL; Spinraza®
Last updated
30 October 2020